The estimated Net Worth of Group Holdings (Sbs) Adviso... is at least $5.58 Миллиард dollars as of 13 February 2020. Group Adviso owns over 2,996,172 units of IQVIA Inc stock worth over $692,690,802 and over the last 8 years Group sold IQV stock worth over $4,886,248,688.
Sign up
Group Adviso IQV stock SEC Form 4 insiders trading
Group has made over 10 trades of the IQVIA Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Group sold 2,919,051 units of IQV stock worth $464,479,395 on 28 July 2020.
The largest trade Group's ever made was selling 6,716,253 units of IQVIA Inc stock on 15 June 2018 worth over $691,774,059. On average, Group trades about 3,507,545 units every 96 days since 2016. As of 13 February 2020 Group still owns at least 2,919,051 units of IQVIA Inc stock.
You can see the complete history of Group Adviso stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Insiders trading at IQVIA Inc
Over the last 7 years, insiders at IQVIA Inc have traded over $7,012,312,980 worth of IQVIA Inc stock and bought 83,468 units worth $15,560,595 . The most active insiders traders include John Connaughton, Pension Plan Investment Boa... и Group Holdings (Sbs) Adviso.... On average, IQVIA Inc executives and independent directors trade stock every 29 days with the average trade being worth of $160,151,634. The most recent stock trade was executed by Eric Sherbet on 27 August 2024, trading 1,300 units of IQV stock currently worth $320,229.
What does IQVIA Inc do?
quintiles and imshealth have merged together to form the new quintilesims. each wanting to bring something new to customers, we deliver integrated information and technology solutions to drive healthcare forward. quintilesims has approximately 50,000 employees conducting operations in more than 100 countries, dedicated to helping our clients improve their clinical, scientific and commercial results. as a global leader in protecting individual patient privacy, quintilesims uses healthcare data to deliver critical, real-world disease and treatment insights. to learn more, visit www.quintilesims.com
What does IQVIA Inc's logo look like?
Complete history of Group Adviso stock trades at IQVIA Inc
IQVIA Inc executives and stock owners
IQVIA Inc executives and other stock owners filed with the SEC include:
-
Ari Bousbib,
Chairman of the Board, President, Chief Executive Officer -
Ari Bousbib,
Chairman, Pres & CEO -
Walter Staub,
President - Research and Development Solutions -
Kevin Knightly,
President - Information and Technology Solutions -
Eric Sherbet,
Executive Vice President, General Counsel, Secretary -
Ronald E. Bruehlman,
Exec. VP & CFO -
W. Richard Staub III,
Pres of R&D Solutions -
Eric M. Sherbet,
Exec. VP, Gen. Counsel & Sec. -
Kevin C. Knightly,
Pres of Technology & Commercial Solutions -
John Leonard,
Lead Independent Director -
Ronald Rittenmeyer,
Independent Director -
Colleen Goggins,
Independent Director -
John Danhakl,
Independent Director -
Carol Burt,
Independent Director -
Ronald Bruehlman,
Interim Chief Financial Officer, Executive Vice President -
Todd Sisitsky,
Independent Director -
James Fasano,
Independent Director -
John Connaughton,
Independent Director -
Trudy Stein,
Chief HR Officer & Exec. VP -
Nicholas Childs,
Sr. VP, Investor Relations & Corp. Communications -
Andrew Markwick,
Sr. VP of Investor Relations & Treasury -
Alejandro Martinez,
Chief Information Officer -
Dr. Jeffrey A. Spaeder,
Sr. VP, Global Chief Medical & Scientific Officer -
Emmanuel N. Korakis,
Sr. VP, Corp. Controller & Principal Accounting Officer -
Michael R Mcdonnell,
EVP and CFO -
W Richard Staub,
See Remarks -
Group Holdings (Sbs) Adviso...,
-
Investment Board Private Ho...,
-
Robert Parks,
Sr Vice President, Controller -
Michael J Evanisko,
Director -
Jack M Greenberg,
Director -
Iii James H Erlinger,
See Remarks -
Pension Plan Investment Boa...,
10% owner -
Pension Plan Investment Boa...,
-
Emmanuel N Korakis,
See Remarks -
Morris Leslie Wims,
Director -
Sheila A Stamps,
Director -
Bhavik Patel,
See Remarks -
Keriann Cherofsky,
See Remarks -
Constantinos Panagos,
See Remarks -
Jim Fasano,
Director